19937 results for «»
19937 results
What do we know about bleeding risk & antithrombotic management after tricuspid valve interventions?
26 Nov 2024 – From PCR London Valves 2024
How do we navigate the thin line between bleeding risk and thrombosis in high-risk patients undergoing tricuspid valve interventions? Marianna Adamo and Fabien Praz explore the latest strategies in anticoagulation, the challenges of managing complex cases and how cutting-edge research is shaping the future of care....
Nurses and Allied Professionals: How does frailty and cognition impact patient selection for TAVI?
26 Nov 2024 – From PCR London Valves 2024
How do frailty and cognitive function shape patient selection for TAVI? Karen Wilson and Lynne Hinterbuchner discuss the essential role of screening and assessment in identifying suitable candidates, highlighting tools like the Edmonton scale and emphasizing the importance of a multidisciplinary approach to prehabilitation.
This interview was...
Mastering structural heart intervention with innovations in imaging
25 Nov 2024 – From PCR London Valves 2024
Explore the future of transcatheter mitral and tricuspid therapies in this innovative session. Learn how advanced imaging techniques like CT/fluoro fusion and 4D intracardiac echocardiography are revolutionizing complex procedures, enhancing both safety and outcomes. Hear from experienced operators as they share their insights on the evolving...
Insights from real-world and post-market evidence on Tricuspid TEER
26 Nov 2024 – From PCR London Valves 2024
In this video, Mirjam Wild, Tobias Kister, and Jonathan Byrne discuss real-world evidence from transcatheter edge-to-edge repair, focusing on the TriCLASP and PACE registries. These studies evaluate the PASCAL Precision system for tricuspid regurgitation and its impact on clinical practice.
This interview was filmed at PCR London...
Aortic valve: PCR London Valves 2024 highlights
26 Nov 2024 – From PCR London Valves 2024
Chris Cook interviews Hélène Eltchaninoff and Bernard Prendergast to discuss the highlights of PCR London Valves 2024, focusing on aortic valve disease. They explore how groundbreaking research, including the EARLY TAVR and COMPARE TAVI trials, is shaping and transforming clinical practice.
This interview was filmed at PCR...
Mitral valve: PCR London Valves 2024 highlights
26 Nov 2024 – From PCR London Valves 2024
Chiara De Biase interviews Sam Dawkins and Francesco Maisano about the PCR London Valves 2024 highlights on mitral valve disease. They highlight sessions analyzing the latest trial evidence, including the two-year data from the MiCLASP and CLASP IID studies. The Congress also stands out for its...
Tricuspid valve disease: PCR London Valves 2024 highlights
26 Nov 2024 – From PCR London Valves 2024
Nicolo Piazza and Fabien Praz join Christopher Cook to highlight the key takeaways from the latest presentations on the tricuspid valve.They evoke the new research and scientific evidence that will have an impact on clinical practice, the rapidly evolving technical innovations and the challenges facing tricuspid...
What is the future role of 3D ICE in tricuspid valve intervention?
26 Nov 2024 – From PCR London Valves 2024
Discover insights on imaging in tricuspid valve management in this engaging PCR London Valves 2024 roundtable discussion with Jennifer Franke, Felix Kreidel, and Azeem Latib.
Explore the potential of 3D intracardiac echocardiography as a cutting-edge tool for advanced imaging, set to transform clinical practice as it adoption...
Predictors and clinical relevance of residual tricuspid regurgitation after transcatheter repair
29 Apr 2025 – From PCR London Valves 2024
Curious about the latest advancements in transcatheter tricuspid valve interventions? Don't miss this discussion between Philipp Lurz and Lukas Stolz as they delve into the topic of residual tricuspid regurgitation after transcatheter repair—a challenge that still needs improvement despite significant progress.
This interview was filmed at PCR...
TRISCEND II Pivotal Trial : How will TTVR impact the treatment of tricuspid regurgitation?
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion, Marianna Adamo, Philipp Lurz, and Sam Dawkins explore the one-year outcomes of the TRISCEND II Pivotal Trial, highlighting its potential to redefine the management of severe tricuspid regurgitation. They delve into the trial’s impact on patients’ quality of life, examine its limitations,...
Impact of late-breaking clinical evidence on your daily mitral TEER practice
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion, Tobias Geisler, Maurizio Taramasso, and Robert Smith delve into the late-breaking trials presented at PCR London Valves 2024. They examine the CLASP IID study, which compares TEER devices for severe mitral regurgitation, and the MiCLASP study, evaluating edge-to-edge therapy approaches. Together, they...
Bicaval TricValve in severe tricuspid regurgitation: one-year outcomes from the Tricbicaval Registry
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion between Angel Sanchez Recalde and Fernando Sarnago, discover the latest updates from the Tricbicaval Registry, as experts discuss the TricValve system for managing severe tricuspid regurgitation. Learn about the patient profiles included in the registry, its promising initial results, and how it...
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
25 Nov 2024 – From PCR London Valves 2024
Through the presentation of several compelling cases, including an 88-year-old male with CKD, RBBB, moderate LV dysfunction, and severe aortic stenosis, a Type 1a bicuspid native AS, and an extraordinary TAVI in an 83-year-old with acute heart failure and comorbidities, this session will dive into the...
Contemporary treatment for Small Aortic Annuli in 2024
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion, Gunasekaran Sengottuvelu, Viveka Kumar, and Haresh Mehta explore optimal treatment strategies and the selection of valve types for challenging anatomies such as small annuli—a condition prevalent in a significant portion of the Indian population.
This interview was filmed at PCR London Valves 2024:...
Mitral valvuloplasty - A new look at an old procedure
24 Nov 2024 – From PCR London Valves 2024
Want to sharpen your expertise in mitral valvuloplasty? This video gets straight to the point: learn the best technical approaches, tackle tough clinical decisions with confidence and discover how to manage mitral stenosis during pregnancy!
Through the lens of a compelling real-world case—a 32-year-old pregnant patient with...
New frontiers in TAVI: have we reached them?
25 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in TAVI as we look into the results of the EARLY TAVR and RHEIA trials. Explore how these groundbreaking findings may influence clinical practice guidelines and shape the future of TAVI, as well as the remaining unmet clinical needs in TAVI.
Tricuspid valve intervention - Current indications and timing
24 Nov 2024 – From PCR London Valves 2024
Curious about the latest breakthroughs in tricuspid valve interventions? This video dives right in, showing you how to assess patients with severe tricuspid regurgitation, interpret imaging and biomarkers and apply cutting-edge evidence from randomized trials to real-world cases.
Through 3 compelling clinical cases—each highlighting different stages and...
Cinch it if you can - Indirect annuloplasty for functional mitral regurgitation
25 Nov 2024 – From PCR London Valves 2024
This session on mitral regurgitation offers an in-depth look at the EMPOWER trial outcomes, indirect annuloplasty in aFMR, and remodeling with the CARILLON device. Explore the benefits of early treatment for secondary mitral regurgitation, understand the role of left ventricular reverse remodeling, and review the latest...
Featured research - Aortic valve (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Dive into the latest research on aortic valve interventions in this two-part featured research session. Explore a wide range of topics, including the safety and efficacy of novel transcatheter aortic valve systems, hemodynamic outcomes, risk scoring, and peri-procedural considerations.
Align for the future with the novel balloon expandable Myval transcatheter heart valve series
26 Nov 2024 – From PCR London Valves 2024
Watch this session to explore expert insights into best-in-class TAVI practices, from pre-procedural imaging and treatment strategy to procedural tips and post-procedural management. Learn from a compelling case study of an 88-year-old male patient with severe symptomatic aortic stenosis treated with the innovative MyVal Octapro THV....
